3 Under-$5B Stocks Nobody Is Talking About (But Should Be)

The S&P 500 just closed at 7,659, down 1.09% on the week, the VIX is back above 16, and the financial internet is arguing about whether the AI bubble is popping. You know what that means: time to dig through the couch cushions of the market and find something interesting that nobody is shouting about.

Here are three small-caps worth your attention right now. None of them are household names. That is exactly the point.

$SMLR (Semler Scientific) is a sub-$500M medical technology company that makes devices used to detect peripheral arterial disease in primary care offices. Under the radar because it lives in the dullest corner of medtech. But the catalyst is real: Medicare reimbursement rates for their QuantaFlo device were held steady in the latest CMS update, removing a key overhang, and the company generates positive free cash flow in a sector full of money-losing startups. Healthcare rotation has been doing real work lately (XLF and XLV have been picking up the slack as tech dumps, per TheChartGuys), and $SMLR fits squarely in that defensive pivot. Bear case: customer concentration risk is high, with a handful of large health systems driving most revenue. Watch the next earnings call for contract renewal language.

$GRPN (Groupon) is probably the one ticker in this list you have actually heard of, but hear this out. The original coupon-zombie company has been executing a genuine turnaround under CEO Dusan Senkypl, slashing its merchant base by over 80% to focus on profitable local experiences rather than discounted mattresses. Market cap sits under $200M. The catalyst: a full-year profitability target that, if hit, would be the first since 2019 and would force a rerating from "meme trash" to "actual business." The bear case is obvious: Groupon has disappointed before, the brand has baggage heavier than a Spirit Airlines carry-on, and consumer spending is under pressure with 44% of Americans struggling to cover basic necessities. High risk, high upside if execution continues.

$FTCI (FTC Solar) is a Texas-based solar tracker manufacturer with a market cap under $300M. Solar trackers are the rails that tilt panels toward the sun, unglamorous but critical infrastructure. FTC is underfollowed because it is not a pure-play panel maker and does not get the residential solar headlines. The catalyst here is a growing utility-scale project backlog and the fact that energy prices staying elevated (Brent crude above $110 makes every alternative energy economics spreadsheet look better) could accelerate project approvals and speed up their order-to-revenue cycle. Bear case: project delays are endemic in utility solar, and the balance sheet is thin.

None of these are sure things. But in a market where everyone is staring at the same overcrowded trades, sometimes the best edge is just looking one screen to the left.